Drug Shortage Report for JAMP-ZOLMITRIPTAN ODT

Last updated on 2021-04-07 History
Report ID 64290
Drug Identification Number 02428237
Brand name JAMP-ZOLMITRIPTAN ODT
Common or Proper name ZOLMITRIPTAN
Company Name JAMP PHARMA CORPORATION
Market Status DORMANT
Active Ingredient(s) ZOLMITRIPTAN
Strength(s) 2.5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 6
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-10-12
Estimated end date 2022-12-30
Actual end date
Shortage status Actual shortage
Updated date 2021-04-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2021-04-07 French Compare
v13 2021-04-07 English Compare
v12 2020-06-19 French Compare
v11 2020-06-19 English Compare
v10 2020-04-29 French Compare
v9 2020-04-29 English Compare
v8 2019-07-08 French Compare
v7 2019-07-08 English Compare
v6 2019-03-01 French Compare
v5 2019-03-01 English Compare
v4 2018-12-19 French Compare
v3 2018-12-19 English Compare
v2 2018-10-15 French Compare
v1 2018-10-15 English Compare

Showing 1 to 14 of 14